{"nct_id":"NCT04196283","title":"A Study to Determine the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ABBV-368 Plus Tilsotolimod and Other Therapy Combinations in Participants With Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma","status":"COMPLETED","status_verified_date":"2023-02","start_date":"2020-01-22","start_date_type":"ACTUAL","primary_completion_date":"2022-10-27","primary_completion_date_type":"ACTUAL","completion_date":"2022-10-27","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["ABBV"]}